ASA-intolerance syndrome and persistent rhinosinusitis. Differential diagnosis and treatment

被引:0
作者
Kirsche, H. [1 ]
Klimek, L. [2 ,3 ]
机构
[1] Univ Klinikum Munster, Klin Hals Nasen Ohrenheilkunde, D-48149 Munster, Germany
[2] Zentrum Rhinol & Allergol, Wiesbaden, Germany
[3] Heidelberg Univ, HNO Univ Klin Mannheim, Mannheim, Germany
关键词
Acetylsalicylic acid; Nasal polyps; Bronchial asthma; Sinusitis; Rhinitis; ASPIRIN DESENSITIZATION-TREATMENT; LONG-TERM TREATMENT; NASAL POLYPOSIS; NATURAL-HISTORY; ASTHMA; SENSITIVITY; PREVALENCE; SAFETY; DRUGS; ACID;
D O I
10.1007/s00106-015-0008-7
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. A differential diagnosis of persistent chronic rhinosinusitis is ASA-intolerance syndrome (AIS), also known as Aspirin (R)-exacerbated respiratory disease (AERD), Samter-Trias (Samter's disease, Morbus Widal). Particularly in cases of frequent recurrency of nasal polyps in combination with bronchial asthma and hypersensitivity reactions to acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAR) can often be referred to an underlying AIS. The pathogenesis of this syndrome is attributed to a misallocation of the arachidonic acid metabolism, resulting in an increased leukotriene production. Methods. The diagnosis may be difficult in the early stages of the disease with incomplete triad of symptoms. Results. Therapy may consist of paranasal sinuses surgery, drug therapy and adaptive deactivation as the only causal treatment option for patients with AIS. Conclusion. For adaptive desactivation, positive effects were actually shown even in patients with long-term recurrent or persistent complaints of chronic rhinosinusitis.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 57 条
  • [31] Safety of Aspirin Desensitization in Patients With Reported Aspirin Allergy and Cardiovascular Disease
    McMullan, Kathryn L.
    Wedner, H. James
    [J]. CLINICAL CARDIOLOGY, 2013, 36 (01) : 25 - 30
  • [32] Aspirin-sensitive asthma
    Morwood, K
    Gillis, D
    Smith, W
    Kette, F
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (04) : 240 - 246
  • [33] OGINO S, 1986, ACTA OTO-LARYNGOL, P21
  • [34] Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: A controlled trial
    Parikh, AA
    Seadding, GK
    [J]. LARYNGOSCOPE, 2005, 115 (08) : 1385 - 1390
  • [35] Polyposis nasi - Improvement in quality of life by the influence of leukotrien receptor antagonists
    Pauli, C.
    Fintelmann, R.
    Klemens, C.
    Hilgert, E.
    Jund, F.
    Rasp, G.
    Hagedorn, H.
    Kramer, M. F.
    [J]. LARYNGO-RHINO-OTOLOGIE, 2007, 86 (04) : 282 - 286
  • [36] Pfaar O, 2006, ALLERGOLOGIE, V29, P322
  • [37] Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements
    Pfaar, Oliver
    Klimek, Ludger
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 6 (03) : 161 - 166
  • [38] Intolerance to nonsteroidal antiinflammatory drugs: Results of controlled drug challenges in 98 patients
    Quiralte, J
    Blanco, C
    Castillo, R
    Delgado, J
    Carrillo, T
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (03) : 678 - 685
  • [39] Role of aspirin desensitization in the management of chronic rhinosinusitis
    Rizk, Habib
    [J]. CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2011, 19 (03) : 210 - 217
  • [40] Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily
    Rozsasi, A.
    Polzehl, D.
    Deutschle, T.
    Smith, E.
    Wiesmiller, K.
    Riechelmann, H.
    Keck, T.
    [J]. ALLERGY, 2008, 63 (09) : 1228 - 1234